http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2036502-A6

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3499352f8f727940717ee8d133d93c2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68
filingDate 1991-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6195f717fc7f08ee23e064912890cb1
publicationDate 1993-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2036502-A6
titleOfInvention IMPROVEMENTS IN THE OBJECT OF PATENT N {9003113 BY PROCEDURE FOR OBTAINING 2-HALOMETIL-3,5-DIMETIL-4-METOXIPIRIDINA HALOHYDRATE.
abstract IMPROVEMENTS IN THE PURPOSE OF PATENT NUM. 9003113 BY PROCEDURE FOR OBTAINING 2-HALOMETIL-3,5-DIMETIL-4-METOXIPIRIDINA HALOHIDRATE, TO OBTAIN PIRIDINE DERIVATIVES FROM FORMULA I BASED ON A FIRST STAGE OF 0-ACILATION AND ACILOXILATION OF THE METHYL 2 GROUP COMPOUND FORMULA BY TREATMENT WITH AN ACRYLING REAGENT, OBTAINING THE COMPOUND FORMULA AND A LAST STAGE OF HALOGENATION, IN WHICH THROUGH A HALOGENANT AGENT, THE SUBSTITUTE IN POSITION 2 BECOMES HALOMETIL. THE DERIVATIVE OF FORMULA I IS A BACKGROUND OF SYNTHESIS OF OMEPRAZOLE, A VERY EFFECTIVE MEDICINE FOR THE TREATMENT OF GASTRIC ULCERS.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009010937-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102225909-A
priorityDate 1991-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594

Total number of triples: 17.